The FDA's drug shortage database lists national shortages by generic name, and when we checked it on October 24, 2026 it carried several ADHD stimulant entries as currently in shortage. A listing does not tell you what one pharmacy has in stock. This guide shows how to search it, what to ask your pharmacist and prescriber, and what not to do.
A DEA and HHS temporary rule lets DEA-registered practitioners prescribe Schedule II to V controlled substances after a video visit, with no prior in-person exam, from January 1 through December 31, 2026. It sets four conditions, leaves state law in place, and expires at the end of the year unless extended. This guide explains what that means for ADHD patients.
In Ontario, BC, and Alberta, the public plan pays for medically necessary physician services, but ADHD assessment often involves other providers or tests that the provinces' public pages do not confirm as insured. Alberta explicitly excludes clinical psychologist services. Medication is covered by separate drug programs. This guide compares the three provinces side by side and shows how to check each part before you pay.
CDC reports that about 30% of US children ages 3 to 17 with current ADHD received neither medication nor behavior treatment in 2022, up from 23% in 2016. The data come from a parent survey, describe groups and not individual children, and do not show why families went without. This article explains the numbers and what to ask a clinician.
The CDC says behavior therapy, specifically parent training, comes first for children under 6, with medication considered for ages 4 to 6 only if behavioral help is not enough. For children 6 and older, treatment can combine FDA-approved medication with parent training or classroom supports. This guide explains each stage and shows what parent training can cost using a public benchmark.
Studies report depression in roughly 19% to 53% of adults with ADHD, and clinicians decide which condition to treat first based on severity. The common antidepressants and bupropion cost pharmacies very little as generics, while therapy is the larger expense. This guide shows the sourced prices, an example therapy budget, and what the evidence says about each option.
Therapy treats emotional and clinical problems and is usually billed to insurance, while ADHD coaching focuses on daily skills and is often not covered. Coaching is unlicensed, and we found no verified national price for it, so this guide explains how to compare cost per session, what each approach is for, and what the research says.
Private clinics rarely publish ADHD evaluation fees, so this guide uses figures that can be checked: Medicare's 2026 national payment for diagnostic evaluations, the prices telehealth companies post on their own sites, and sliding-scale options such as FQHCs and Open Path. It also explains how to request a written quote before you book.
In US children, ADHD is diagnosed in 13% of boys and 7% of girls, yet by adulthood the ratio nears 1 to 1, which suggests many girls were missed. Masking, a quieter inattentive presentation, and misdiagnosis with other conditions can delay care. This guide explains what research supports, what remains uncertain about hormones, and how to prepare for an evaluation.
The federal government publishes what pharmacies pay for each ADHD drug, and brand-name versions cost pharmacies several times more than generics. What you pay is higher than the pharmacy's cost and depends on your insurance, so this guide shows the federal prices, average insurance copays, Medicaid limits, and how to get your own cash price.